Detect scores EUA from FDA for at-home molecular COVID-19 test
Health tech company Detect announced Friday it had received emergency use authorization from the Food and Drug Administration for its at-home molecular COVID-19 test.
The Detect test uses an app to help users perform and interpret their results. The company said it’s also working on an electronic travel pass system with a telehealth service so its offering can be used for travel and events.
“The Detect COVID-19 Test brings laboratory accuracy into the home, helping to mitigate COVID-19 transmission and make everyday activities safe and anxiety-free again,” Dr. Jonathan Rothberg, founder of Detect, said in a statement.
“As a complement to vaccines, highly accurate rapid testing will be critical as the pandemic becomes endemic. We developed the Detect COVID-19 Test to help people return to doing the things they love with the people they love in the safest way possible.”
WHY IT MATTERS
Detect is pitching its COVID-19 test as a more accurate option that can be done in an hour at home, without the need for lab analysis.
The company said the Detect test showed 97.3{eca2258439cb6473656e03a2d3e6b84304b35fc01c093883e008a47bacba1047} overall agreement with a polymerase chain reaction (PCR) test, typically performed in a lab.
Most at-home tests are antigen tests, which